Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties

Microvascular Research

Volumn 71, Issue 3, 2006, Pages 222-226

  Yamagishi, Sho ichi ^a   Matsui, Takanori ^a   Nakamura, Kazuo ^a   Yoshida, Takafumi ^a   Shimizu, Kyoko ^b   Takegami, Yoshiaki ^b   Shimizu, Tadamichi ^b   Inoue, Hiroyoshi ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Angiogenesis; Angiotensin II; PEDF; ROS

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN II ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; HYDROGEN PEROXIDE; MESSENGER RNA; OLMESARTAN; PIGMENT EPITHELIUM DERIVED FACTOR; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; T LYMPHOCYTE; UPREGULATION;

ANGIOTENSIN II; BASE SEQUENCE; CELL LINE; EYE PROTEINS; HUMANS; MUTATION; NERVE GROWTH FACTORS; RAC1 GTP-BINDING PROTEIN; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SERPINS; T-LYMPHOCYTES; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646931160     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2006.03.001     Document Type: Article

References (22)

1. Brasier A.R., Recinos III A., and Eledrisi M.S. Vascular inflammation and the renin-angiotensin system. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1257-1266
2. Cheng S.M., Yang S.P., Ho L.J., Tsao T.P., Cheng D.M., and Lai J.H. Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1. Br. J. Pharmacol. 142 (2004) 933-942
3. Dawson D.W., Volpert O.V., Gillis P., Crawford S.E., Xu H.J., Benedict W., and Bouck N.P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285 (1999) 245-248
4. Duh E.J., Yang H.S., Suzuma I., Miyagi M., Youngman E., Mori K., Katai M., Yan L., Suzuma K., West K., Davarya S., Tong P., Gehlbach P., Pearlman J., Crabb J.W., Aiello L.P., Campochiaro P.A., and Zack D.J. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Visual Sci. 43 (2002) 821-829
5. Egami K., Murohara T., Shimada T., Sasaki K., Shintani S., Sugaya T., Ishii M., Akagi T., Ikeda H., Matsuishi T., and Imaizumi T. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J. Clin. Invest. 112 (2003) 67-75
6. Freeman M.R., Schneck F.X., Gagnon M.L., Corless C., Soker S., Niknejad K., Peoples G.E., and Klagsbrun M. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 55 (1995) 4140-4145
7. Fujita M., Hayashi I., Yamashina S., Fukamizu A., Itoman M., and Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 26 (2005) 271-279
8. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74 (1994) 1141-1148
9. Monaco C., Andreakos E., Kiriakidis S., Feldmann M., and Paleolog E. T-cell-mediated signaling in immune, inflammatory and angiogenic process: the cascade of events leading to inflammatory diseases. Curr. Drug Targets Inflamm. Allergy 3 (2004) 35-42
10. Mor F., Quintana F.J., and Cohen I.R. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J. Immunol. 172 (2004) 4618-4623
11. Petersen S.V., Valnickova Z., and Enghild J.J. Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. Biochem. J. 15 (2003) 199-206
12. Sasaki K., Murohara T., Ikeda H., Sugaya T., Shimada T., Shintani S., and Imaizumi T. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J. Clin. Invest. 109 (2002) 603-611
13. Tamarat R., Silvestre J.S., Durie M., and Levy B.I. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab. Invest. 82 (2002) 747-756
14. Tombran-Tink J., Chader C.G., and Johnson L.V. PEDF: pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res. 53 (1991) 411-414
15. Ushio-Fukai M., and Alexander R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol. Cell. Biochem. 264 (2004) 85-97
16. Yamagishi S., Edelstein D., Du X.L., and Brownlee M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 50 (2001) 1491-1494
17. Yamagishi S., Inagaki Y., Amano S., Okamoto T., Takeuchi M., and Makita Z. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochem. Biophys. Res. Commun. 296 (2002) 877-882
18. Yamagishi S., Inagaki Y., Okamoto T., Amano S., Koga K., Takeuchi M., and Makita Z. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J. Biol. Chem. 277 (2002) 20309-20315
19. Yamagishi S., Amano S., Inagaki Y., Okamoto T., Takeuchi M., and Inoue H. Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through its anti-oxidative properties. Microvasc. Res. 65 (2003) 186-190
20. Yamagishi S., Inagaki Y., Nakamura K., Abe R., Shimizu T., Yoshimura A., and Imaizumi T. Pigment epithelium-derived factor inhibits TNF-α-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. J. Mol. Cell. Cardiol. 37 (2004) 497-506
21. Yamagishi S., Nakamura K., Ueda S., Kato S., and Imaizumi T. Pigment epithelium-derived factor blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res. 320 (2005) 437-445
22. Yoshiji H., Kuriyama S., Noguchi R., and Fukui H. Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy. Curr. Cancer Drug Targets 4 (2004) 5555-5567